These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11872892)

  • 21. Paradoxical embolism with a patent foramen ovale and atrial septal aneurysm.
    Beacock DJ; Watt VB; Oakley GD; Al Mohammad A
    Eur J Echocardiogr; 2006 Mar; 7(2):171-4. PubMed ID: 15914088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events.
    Yahia AM; Shaukat A; Kirmani JF; Qureshi AI
    Echocardiography; 2004 Aug; 21(6):517-22. PubMed ID: 15298687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI.
    Santamarina E; González-Alujas MT; Muñoz V; Rovira A; Rubiera M; Ribó M; Alvarez-Sabin J; Molina CA
    J Neuroimaging; 2006 Oct; 16(4):334-40. PubMed ID: 17032383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause.
    Berthet K; Lavergne T; Cohen A; Guize L; Bousser MG; Le Heuzey JY; Amarenco P
    Stroke; 2000 Feb; 31(2):398-403. PubMed ID: 10657412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indication to occlusion of patent foramen ovale in patient with pulmonary hypertension after a cardioembolic stroke].
    Svobodová I; Belohlávek J; Grünfeldová H; Linhart A
    Cas Lek Cesk; 2007; 146(4):407-10. PubMed ID: 17491252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?
    Rigatelli G; Aggio S; Cardaioli P; Braggion G; Giordan M; Dell'avvocata F; Chinaglia M; Rigatelli G; Roncon L; Chen JP
    JACC Cardiovasc Interv; 2009 Jul; 2(7):655-62. PubMed ID: 19628189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Migraine as predictive factor of the presence of atrial septum aneurysm in patients with stroke and patent foramen ovale].
    Martín Balbuena S; Fuentes B; Lara M; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Neurologia; 2009 Apr; 24(3):160-4. PubMed ID: 19418291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal arterial occlusion and patent foramen ovale: A case study-based review.
    Fekri S; Mahmoudimehr P; Jafari Fesharaki M; Hosseinjani E; Abtahi SH; Nouri H
    J Fr Ophtalmol; 2024 Jan; 47(1):104021. PubMed ID: 37951744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
    Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
    J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke.
    Ghosh S; Ghosh AK; Ghosh SK
    Postgrad Med J; 2007 Mar; 83(977):173-7. PubMed ID: 17344571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Atrial Septal Anatomy Still Matter in the Etiological Evaluation of Ischemic Stroke Beyond the Age of 60?
    Dusonchet A; Varenne O; Puscas T; Saadi M; Hagege A; Calvet D; Mas JL; Turc G
    J Am Heart Assoc; 2024 Feb; 13(4):e031684. PubMed ID: 38353217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
    Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
    Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Messé SR; Silverman IE; Kizer JR; Homma S; Zahn C; Gronseth G; Kasner SE;
    Neurology; 2004 Apr; 62(7):1042-50. PubMed ID: 15078999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prevalence of patent foramen ovale in patients with migraine].
    Domitrz I; Mieszkowski J; Kwieciński H
    Neurol Neurochir Pol; 2004; 38(2):89-92. PubMed ID: 15307600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of patent foramen ovale and of the Eustaquian valve in the trhomboembolic events].
    Magalhães E; Torreão J; Costa N; Freitas N; Melo A
    Arq Neuropsiquiatr; 2006 Jun; 64(2A):245-8. PubMed ID: 16791364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patent foramen ovale and stroke.
    Horton SC; Bunch TJ
    Mayo Clin Proc; 2004 Jan; 79(1):79-88. PubMed ID: 14708951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.
    Meissner I; Khandheria BK; Heit JA; Petty GW; Sheps SG; Schwartz GL; Whisnant JP; Wiebers DO; Covalt JL; Petterson TM; Christianson TJ; Agmon Y
    J Am Coll Cardiol; 2006 Jan; 47(2):440-5. PubMed ID: 16412874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
    Homma S; DiTullio MR; Sacco RL; Sciacca RR; Mohr JP;
    Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.